(MBB) MBB INDUSTRIES - Ratings and Ratios
IT Security, Specialty Machinery, Tissue Products, Mattresses, Plant Engineering
Dividends
| Dividend Yield | 1.67% |
| Yield on Cost 5y | 3.23% |
| Yield CAGR 5y | 9.60% |
| Payout Consistency | 91.6% |
| Payout Ratio | 31.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 33.8% |
| Value at Risk 5%th | 47.8% |
| Relative Tail Risk | -14.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.02 |
| Alpha | 95.26 |
| CAGR/Max DD | 0.96 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.493 |
| Beta | 0.143 |
| Beta Downside | 0.262 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.85% |
| Mean DD | 12.59% |
| Median DD | 11.63% |
Description: MBB MBB INDUSTRIES November 18, 2025
MBB SE (XETRA:MBB) is a German-based industrial conglomerate that acquires and runs medium-sized firms across technology and engineering. It is organized into three segments: Service & Infrastructure (IT-security, cloud services, and pipeline/plant engineering for gas, power grids and emerging hydrogen networks); Technological Applications (specialty machinery and automated lines for e-mobility, plus eco-friendly hardwood components for automotive, rail and safety markets); and Consumer Goods (paper hygiene products under the “aha” brand and sleep-system items such as mattresses and pillows). The group was founded in 1995 and is headquartered in Berlin.
Key metrics from the most recent FY 2023 filing show revenue of roughly €1.2 billion, an EBITDA margin of 8 % and a net-debt-to-EBITDA ratio of 0.6, indicating moderate leverage. The Service & Infrastructure segment benefits from the EU’s hydrogen-investment roadmap, which is projected to drive a 12 % CAGR in hydrogen-related infrastructure spending through 2030. Meanwhile, the Technological Applications arm is positioned to capture growth in e-mobility production, where global vehicle-electric-powertrain output is expected to rise at 15 % CAGR, and the Consumer Goods division provides a stable cash-flow buffer in a low-inflation, high-volume hygiene market.
If you want a data-rich, quantitative deep-dive on MBB’s valuation assumptions and scenario analysis, the ValueRay platform offers a transparent dashboard that can help you assess the trade-off between its industrial exposure and cash-generating consumer segment.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (54.2m TTM) > 0 and > 6% of Revenue (6% = 70.0m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 0.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.21% (prev 44.10%; Δ 2.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 151.4m > Net Income 54.2m (YES >=105%, WARN >=100%) |
| Net Debt (-327.8m) to EBITDA (137.5m) ratio: -2.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (5.32m) change vs 12m ago 0.05% (target <= -2.0% for YES) |
| Gross Margin 49.01% (prev 27.96%; Δ 21.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 95.38% (prev 88.19%; Δ 7.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.55 (EBITDA TTM 137.5m / Interest Expense TTM 11.7m) >= 6 (WARN >= 3) |
Altman Z'' 4.02
| (A) 0.42 = (Total Current Assets 800.1m - Total Current Liabilities 261.3m) / Total Assets 1.28b |
| (B) 0.13 = Retained Earnings (Balance) 169.6m / Total Assets 1.28b |
| (C) 0.08 = EBIT TTM 100.2m / Avg Total Assets 1.22b |
| (D) 0.26 = Book Value of Equity 174.9m / Total Liabilities 680.4m |
| Total Rating: 4.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.49
| 1. Piotroski 6.0pt |
| 2. FCF Yield 18.92% |
| 3. FCF Margin 9.90% |
| 4. Debt/Equity 0.10 |
| 5. Debt/Ebitda -2.38 |
| 6. ROIC - WACC (= 4.81)% |
| 7. RoE 9.55% |
| 8. Rev. Trend 78.68% |
| 9. EPS Trend 66.25% |
What is the price of MBB shares?
Over the past week, the price has changed by +8.23%, over one month by +5.93%, over three months by +19.76% and over the past year by +100.93%.
Is MBB a buy, sell or hold?
What are the forecasts/targets for the MBB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 230.6 | 15.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 224 | 12% |
MBB Fundamental Data Overview December 08, 2025
Market Cap EUR = 998.5m (998.5m EUR * 1.0 EUR.EUR)
P/E Trailing = 18.3515
P/S = 0.8365
P/B = 1.6549
Beta = 0.963
Revenue TTM = 1.17b EUR
EBIT TTM = 100.2m EUR
EBITDA TTM = 137.5m EUR
Long Term Debt = 32.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 16.1m EUR (from shortLongTermDebt, last quarter)
Debt = 62.3m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -327.8m EUR (from netDebt column, last fiscal year)
Enterprise Value = 610.3m EUR (998.5m + Debt 62.3m - CCE 450.4m)
Interest Coverage Ratio = 8.55 (Ebit TTM 100.2m / Interest Expense TTM 11.7m)
FCF Yield = 18.92% (FCF TTM 115.4m / Enterprise Value 610.3m)
FCF Margin = 9.90% (FCF TTM 115.4m / Revenue TTM 1.17b)
Net Margin = 4.64% (Net Income TTM 54.2m / Revenue TTM 1.17b)
Gross Margin = 49.01% ((Revenue TTM 1.17b - Cost of Revenue TTM 594.6m) / Revenue TTM)
Gross Margin QoQ = 51.52% (prev 49.88%)
Tobins Q-Ratio = 0.48 (Enterprise Value 610.3m / Total Assets 1.28b)
Interest Expense / Debt = 13.26% (Interest Expense 8.26m / Debt 62.3m)
Taxrate = 30.01% (15.5m / 51.8m)
NOPAT = 70.1m (EBIT 100.2m * (1 - 30.01%))
Current Ratio = 3.06 (Total Current Assets 800.1m / Total Current Liabilities 261.3m)
Debt / Equity = 0.10 (Debt 62.3m / totalStockholderEquity, last quarter 599.1m)
Debt / EBITDA = -2.38 (Net Debt -327.8m / EBITDA 137.5m)
Debt / FCF = -2.84 (Net Debt -327.8m / FCF TTM 115.4m)
Total Stockholder Equity = 567.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.23% (Net Income 54.2m / Total Assets 1.28b)
RoE = 9.55% (Net Income TTM 54.2m / Total Stockholder Equity 567.2m)
RoCE = 16.71% (EBIT 100.2m / Capital Employed (Equity 567.2m + L.T.Debt 32.6m))
RoIC = 11.51% (NOPAT 70.1m / Invested Capital 609.4m)
WACC = 6.70% (E(998.5m)/V(1.06b) * Re(6.54%) + D(62.3m)/V(1.06b) * Rd(13.26%) * (1-Tc(0.30)))
Discount Rate = 6.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.49%
[DCF Debug] Terminal Value 71.83% ; FCFE base≈108.0m ; Y1≈75.4m ; Y5≈39.0m
Fair Price DCF = 141.3 (DCF Value 752.4m / Shares Outstanding 5.32m; 5y FCF grow -35.40% → 3.0% )
EPS Correlation: 66.25 | EPS CAGR: 41.78% | SUE: N/A | # QB: 0
Revenue Correlation: 78.68 | Revenue CAGR: 16.50% | SUE: 0.28 | # QB: 0
EPS next Year (2026-12-31): EPS=10.80 | Chg30d=+1.547 | Revisions Net=+2 | Growth EPS=-0.5% | Growth Revenue=+1.8%